---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-050406"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:29:19.492670+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences enters agreement to receive $750,000 and transfer certain patent assets

## Summary
- A third party agreed to pay Arcadia $750,000 as part of the agreement.
- The third party transferred back to Arcadia all rights and materials related to certain intellectual property and traits previously licensed.
- Arcadia transferred its reduced gluten and oxidative stability granted patents and pending applications to the third party.
- The parties amended a prior agreement to eliminate any future product royalty obligations payable to Arcadia.

## SEC filing metadata
- accession: 0000950170-25-050406
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017025050406/0000950170-25-050406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017025050406/rkda-20250328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-050406
- JSON: https://secwatch.observer/filing/0000950170-25-050406.json
- Plain text: https://secwatch.observer/filing/0000950170-25-050406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.